Prestige Brands Holdings, Inc. (NYSE:PBH) will present and answer
questions at the Morgan Stanley Global Consumer Conference today at the
Crown Plaza Hotel in New York City.
Matthew M. Mannelly, CEO of Prestige Brands, will speak about the
Company’s strategic approach to creating shareholder value, review
recent acquisition activity and discuss the outlook for fiscal year
2015. A copy of his presentation will be available in the Investor
Relations section of the Company’s website, www.prestigebrands.com.
About Prestige Brands Holdings, Inc.
The Company markets and distributes brand name over-the-counter
healthcare and household cleaning products throughout the U.S., Canada
and Australia and in other international markets. Core brands include
Monistat® yeast infection treatment, Nix® lice treatment, Chloraseptic®
sore throat treatments, Clear Eyes® eye care products, Compound W® wart
treatments, The Doctor’s® NightGuard® dental protector, the Little
Remedies® and PediaCare® lines of pediatric over-the-counter products,
Efferdent® denture care products, Luden’s® throat drops, Dramamine®
motion sickness treatment, BC® and Goody’s® pain relievers, Beano® gas
prevention, Debrox® earwax remover, and Gaviscon® antacid in Canada.
Copyright Business Wire 2014